Intensity Modulated Proton Therapy After Surgery for the Treatment of Head and Neck Cancer, the HEADLIGHT Study
Conditions:   Head and Neck Carcinoma;   Head and Neck Carcinoma of Unknown Primary;   Hypopharyngeal Carcinoma;   Laryngeal Carcinoma;   Metastatic Malignant Neoplasm in the Lymph Nodes;   Nasal Cavity Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Carcinoma;   Paranasal S inus Carcinoma;   Salivary Gland Carcinoma;   Skin Carcinoma Interventions:   Drug: Cisplatin;   Procedure: Intensity-Modulated Proton Therapy;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Mayo Clinic;   National Cancer Institute (NCI) Not yet recruiti...
Source: ClinicalTrials.gov - October 13, 2021 Category: Research Source Type: clinical trials